Evidence map›Paper›PMID 25360081›Full record

ArticleFrontiers in molecular neuroscience2014

Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice.

Sara E Gombash, Christopher J Cowley, Julie A Fitzgerald, Jodie C E Hall, Christian Mueller, Fedias L Christofi, Kevin D Foust

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Optogenetic control of the enteric nervous system and gastrointestinal transit.Expert review of gastroenterology & hepatology · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sara E GombashDepartment of Neuroscience, Ohio State University Columbus, OH, USA.
Christopher J CowleyDepartment of Neuroscience, Ohio State University Columbus, OH, USA.
Julie A FitzgeraldDepartment of Neuroscience, Ohio State University Columbus, OH, USA.
Jodie C E HallDepartment of Neuroscience, Center for Brain and Spinal Cord Repair, Ohio State University Columbus, OH, USA.
Christian MuellerDepartment of Pediatrics, Gene Therapy Center, University of Massachusetts Medical School Worcester, MA, USA.
Fedias L ChristofiDepartment of Anesthesiology, Ohio State University Columbus, OH, USA.
Kevin D FoustDepartment of Neuroscience, Ohio State University Columbus, OH, USA.
The Ohio State University · USUniversity of Massachusetts Chan Medical School · US

Funding

Neuroimaging of Purinergic Pathways in the Human ENSR01DK093499 · NIDDK · OHIO STATE UNIVERSITY · PI CHRISTOFI, FEDIAS LEONTIOU · 2012 to 2015
$1.3M
Training in neuromuscular diseasesT32NS077984 · NINDS · OHIO STATE UNIVERSITY · PI GUTTRIDGE, DENIS C, MENDELL, JERRY ROY · 2012 to 2016
$946k
NIDDK NIH HHS R01 DK093499NINDS NIH HHS T32 NS077984
6 · The paper itself

Abstract

Gene therapies for neurological diseases with autonomic or gastrointestinal involvement may require global gene expression. Gastrointestinal complications are often associated with Parkinson's disease and autism. Lewy bodies, a pathological hallmark of Parkinson's brains, are routinely identified in the neurons of the enteric nervous system (ENS) following colon biopsies from patients. The ENS is the intrinsic nervous system of the gut, and is responsible for coordinating the secretory and motor functions of the gastrointestinal tract. ENS dysfunction can cause severe patient discomfort, malnourishment, or even death as in intestinal pseudo-obstruction (Ogilvie syndrome). Importantly, ENS transduction following systemic vector administration has not been thoroughly evaluated. Here we show that systemic injection of AAV9 into neonate or juvenile mice results in transduction of 25-57% of ENS myenteric neurons. Transgene expression was prominent in choline acetyltransferase positive cells, but not within vasoactive intestinal peptide or neuronal nitric oxide synthase cells, suggesting a bias for cells involved in excitatory signaling. AAV9 transduction in enteric glia is very low compared to CNS astrocytes. Enteric glial transduction was enhanced by using a glial specific promoter. Furthermore, we show that AAV8 results in comparable transduction in neonatal mice to AAV9 though AAV1, 5, and 6 are less efficient. These data demonstrate that systemic AAV9 has high affinity for peripheral neural tissue and is useful for future therapeutic development and basic studies of the ENS.

Indexed as

AAV9adeno-associated virusenteric gliaenteric nervous systementeric neuropathyfunctional gastrointestinal motility disordersgene therapymyenteric plexus

Identifiers

PMID25360081
PMCPMC4197761
OpenAlexW2004578280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.